The pathogenesis of Parkinson's disease: a new hypothesis.
作者信息
BARBEAU A
出版信息
Can Med Assoc J. 1962 Oct 13;87(15):802-7.
Abstract
摘要
相似文献
1
The pathogenesis of Parkinson's disease: a new hypothesis.
Can Med Assoc J. 1962 Oct 13;87(15):802-7.
2
Section of U fibers of motor cortex in cases of paralysis agitans (Parkinson's disease); report of 9 cases.
Arch Neurol Psychiatry. 1950 Jul;64(1):57-9. doi: 10.1001/archneurpsyc.1950.02310250063004.
3
[Parkinson's syndrome of tumurous origin].
Acta Neurol Psychiatr Belg. 1952 Nov;52(11):737-65.
4
The pathogenesis of Parkinson's disease.
Can Med Assoc J. 1963 Jan 5;88:46-7.
5
[On the Pathogenesis of Parkinson's Disease].
Nervenarzt. 1957 Feb 20;28(2):53-6.
6
The psychiatric complications of Parkinson's disease.
Aust N Z J Psychiatry. 1986 Jun;20(2):114-21. doi: 10.3109/00048678609161325.
7
[Critical study of the Cooper operation (ligation of the anterior choroidal artery) in Parkinson's disease].
Arq Neuropsiquiatr. 1955 Mar;13(1):13-32. doi: 10.1590/s0004-282x1955000100002.
8
[Dopamine (3-hydroxytyramine) in the central nervous system and its relation to the Parkinson syndrome in man].
Dtsch Med Wochenschr. 1962 Sep 7;87:1807-10. doi: 10.1055/s-0028-1114024.
9
[New treatments of Parkinson's disease].
J Med Bord. 1952 Jun;129(6):503-7.
10
Dyspnea as a symptom in parkinson's syndrome.
Am Rev Tuberc. 1958 Nov;78(5):682-91. doi: 10.1164/artpd.1958.78.5.682.
引用本文的文献
1
Extrinsic and intrinsic control of striatal cholinergic interneuron activity.
Front Mol Neurosci. 2025 Feb 13;18:1528419. doi: 10.3389/fnmol.2025.1528419. eCollection 2025.
2
Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors.
Sci Adv. 2024 Nov 22;10(47):eadp6301. doi: 10.1126/sciadv.adp6301. Epub 2024 Nov 20.
3
Synchronous activation of striatal cholinergic interneurons induces local serotonin release.
bioRxiv. 2024 Dec 11:2024.11.03.621726. doi: 10.1101/2024.11.03.621726.
4
A mismatch between striatal cholinergic pauses and dopaminergic reward prediction errors.
Proc Natl Acad Sci U S A. 2024 Oct 8;121(41):e2410828121. doi: 10.1073/pnas.2410828121. Epub 2024 Oct 4.
5
The primary cilium of cholinergic neurons may be a linchpin in the progression of Parkinson's Disease.
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2414226121. doi: 10.1073/pnas.2414226121. Epub 2024 Sep 17.
6
Spatially organized striatal neuromodulator release encodes trajectory errors.
bioRxiv. 2024 Aug 14:2024.08.13.607797. doi: 10.1101/2024.08.13.607797.
7
Dopamine and glutamate regulate striatal acetylcholine in decision-making.
Nature. 2023 Sep;621(7979):577-585. doi: 10.1038/s41586-023-06492-9. Epub 2023 Aug 9.
8
Targeting the Actions of Muscarinic Receptors on Dopamine Systems: New Strategies for Treating Neuropsychiatric Disorders.
Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:277-289. doi: 10.1146/annurev-pharmtox-051921-023858. Epub 2023 Aug 9.
9
The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disorders.
Biochem Soc Trans. 2023 Apr 26;51(2):691-702. doi: 10.1042/BST20220525.
10
Synaptic determinants of cholinergic interneurons hyperactivity during parkinsonism.
Front Synaptic Neurosci. 2022 Sep 6;14:945816. doi: 10.3389/fnsyn.2022.945816. eCollection 2022.
本文引用的文献
1
Functional grafts of the anterior pituitary gland.
Proc R Soc Lond B Biol Sci. 1952 Feb 28;139(895):263-76. doi: 10.1098/rspb.1952.0011.
2
A cerebral decarboxylase for 5-hydroxytryptophane in humans.
J Appl Physiol. 1961 Nov;16:1050-4. doi: 10.1152/jappl.1961.16.6.1050.
3
4
Distribution of catechol compounds in human brain.
Biochim Biophys Acta. 1959 Apr;32:586-7. doi: 10.1016/0006-3002(59)90652-3.
5
A place for histamine in normal physiology.
Lancet. 1960 Jan 9;1(7115):67-71. doi: 10.1016/s0140-6736(60)92896-8.
6
[Distribution of the substance P and cholinacetylase in the brain].
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1955;224(2):159-75.
7
Differences in central anticholinergic actions of phenothiazine derivatives.
Exp Neurol. 1961 Oct;4:317-29. doi: 10.1016/0014-4886(61)90058-9.
8
Phenothiazines: curative or causative in regard to parkinsonism?
Rev Can Biol. 1961 Jun;20:289-94.
9
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].
Wien Klin Wochenschr. 1961 Nov 10;73:787-8.
10
[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].
Klin Wochenschr. 1961 Oct 15;39:1056-9. doi: 10.1007/BF01487648.
Zotero 插件